These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10968196)

  • 21. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 27. Prior calcium channel blockade and short-term survival following acute myocardial infarction.
    Parsons RW; Hung J; Hanemaaijer I; Jbroadhurst R; Jamrozik K; Hobbs MS
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):487-92. PubMed ID: 11916357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Jeffers BW; Robbins J; Bhambri R
    Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Calcium antagonists in cardiovascular diseases--a valuable controversy, but unnecessary panic].
    Messerli FH
    Ther Umsch; 1999 Jan; 56(1):43-8. PubMed ID: 10067134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium-channel blockers in ischemic heart disease.
    Silvestry FE; Kimmel SE
    Curr Opin Cardiol; 1996 Jul; 11(4):434-9. PubMed ID: 8879955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High blood pressure and calcium antagonism.
    Palma-Gámiz JL
    Cardiology; 1997; 88 Suppl 1():39-46. PubMed ID: 9118167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
    Jonas M; Goldbourt U; Boyko V; Mandelzweig L; Behar S; Reicher-Reiss H
    Cardiovasc Drugs Ther; 1998 May; 12(2):177-81. PubMed ID: 9652876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nifedipine study.
    Lichtlen PR
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641040
    [No Abstract]   [Full Text] [Related]  

  • 34. Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension.
    Flynn JT; Pasko DA
    Pediatr Nephrol; 2000 Dec; 15(3-4):302-16. PubMed ID: 11149130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy).
    Schulz J; Schmidt J; Rück W
    Curr Med Res Opin; 1996; 13(7):397-408. PubMed ID: 8862939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.
    Lubsen J; Wagener G; Kirwan BA; de Brouwer S; Poole-Wilson PA;
    J Hypertens; 2005 Mar; 23(3):641-8. PubMed ID: 15716708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium channel blockers in the spectrum of antihypertensive agents.
    Liebson PR
    Expert Opin Pharmacother; 2006 Dec; 7(17):2385-401. PubMed ID: 17109613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Palmer CR; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    Lancet; 2000 Jul; 356(9227):366-72. PubMed ID: 10972368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
    Tardif JC; Ducharme A; Yu H; Wogen J; Guertin MC
    Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses.
    Opie LH
    Am J Hypertens; 2001 Oct; 14(10):1074-81. PubMed ID: 11710789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.